Iterum Therapeutics Plc (NASDAQ:ITRM)’s traded shares stood at 0.87 million during the latest session, with the company’s beta value hitting 2.43.The ITRM share’s 52-week high
During the last session, Iterum Therapeutics Plc (NASDAQ:ITRM)’s traded shares were 0.5 million, with the beta value of the company hitting 2.25. At the end
Iterum Therapeutics Plc (NASDAQ:ITRM)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting 2.29.The ITRM share’s 52-week high
In the latest trading session, 0.4 million Iterum Therapeutics Plc (NASDAQ:ITRM) shares changed hands as the company’s beta touched 2.29. With the company’s most recent
During the last session, Iterum Therapeutics Plc (NASDAQ:ITRM)’s traded shares were 0.47 million, with the beta value of the company hitting 2.28. At the end
Iterum Therapeutics Plc (NASDAQ:ITRM)’s traded shares stood at 0.8 million during the last session, with the company’s beta value hitting 2.31. At the close of
Iterum Therapeutics Plc (NASDAQ:ITRM)’s traded shares stood at 1.54 million during the last session, with the company’s beta value hitting 2.32. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
